The Art of Bioimmunogenomics (BIGs) 5.0 in CAR-T Cell Therapy for Lymphoma Management

The Art of Bioimmunogenomics (BIGs) 5.0 in CAR-T Cell Therapy for Lymphoma Management

Purpose: Lymphoma, the most predominant neoplastic disorder, is divided into Hodgkin and Non-Hodgkin Lymphoma classifications. Immunotherapeutic modalities have emerged as essential methodologies in combating lymphoid malignancies. Chimeric Antigen Receptor (CAR) T cells exhibit promising responses...

Full description

Saved in:
Bibliographic Details
Main Authors: Dito Anurogo, Dewi Luthfiana, Nuralfin Anripa, Apriliani Ismi Fauziah, Maratu Soleha, Laila Rahmah, Hana Ratnawati, Teresa Liliana Wargasetia, Sari Eka Pratiwi, Riswal Nafi Siregar, Ratis Nour Sholichah, Muhammad Sobri Maulana, Taruna Ikrar, Yu Hsiang Chang, Jiantai Timothy Qiu
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2024-07-01
Series:Advanced Pharmaceutical Bulletin
Subjects:
car-t cells
lymphoma
management
Online Access:https://apb.tbzmed.ac.ir/PDF/apb-14-314.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items